Cargando…

Nonmedical Use of Xtampza(®) ER and Other Oxycodone Medications in Adults Evaluated for Substance Abuse Treatment: Real-World Data from the Addiction Severity Index-Multimedia Version (ASI-MV(®))

PURPOSE: The purpose of this study was to evaluate real-world data related to past 30-day nonmedical use (NMU) and routes of administration of Xtampza(®) ER and comparator oxycodone medications in the US as captured within the Addiction Severity Index-Multimedia Version(®) (ASI-MV(®)). METHODS: Data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Green, Jody L, Robbins, Rebekkah S, Dailey-Govoni, Taryn, Butler, Stephen F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214548/ https://www.ncbi.nlm.nih.gov/pubmed/34163234 http://dx.doi.org/10.2147/JPR.S304805

Ejemplares similares

Real-World Data on Nonmedical Use of Tramadol from Patients Evaluated for Substance Abuse Treatment in the NAVIPPRO Addiction Severity Index—Multimedia Version (ASI-MV(®)) Network
por: Green, Jody L., et al.
Publicado: (2020)

Evaluation of Abuse and Route of Administration of Extended-Release Tapentadol Among Treatment-Seeking Individuals, as Captured by the Addiction Severity Index–Multimedia Version (ASI-MV)
por: Vosburg, Suzanne K, et al.
Publicado: (2019)

Oral Human Abuse Potential of Oxycodone DETERx(®) (Xtampza(®) ER)
por: Kopecky, Ernest A., et al.
Publicado: (2016)

Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza ER
por: Geoffrey Severtson, Stevan, et al.
Publicado: (2020)

Characterizing the Experience of Tapentadol Nonmedical Use: Mixed Methods Study
por: Vosburg, Suzanne K, et al.
Publicado: (2022)

A US Retrospective Claims Analysis Comparing Healthcare Costs of Patients Transitioning from Immediate-Release Oxycodone to Two Different Formulations of Extended-Release Oxycodone: Xtampza ER or OxyContin
por: Olatoke, Oluwadara, et al.
Publicado: (2022)

Associations between prescription stimulant use as prescribed, nonmedical use, and illicit stimulant use among adults evaluated for substance use treatment, 2017-2021
por: Pickens, Cassandra M., et al.
Publicado: (2023)

Characterizing prescription stimulant nonmedical use (NMU) among adults recruited from Reddit
por: Vosburg, Suzanne K., et al.
Publicado: (2021)

In Vitro Drug Release After Crushing: Evaluation of Xtampza(®) ER and Other ER Opioid Formulations
por: Mayock, Stephen P., et al.
Publicado: (2017)

Characteristics of Adults Aged ≥18 Years Evaluated for Substance Use and Treatment Planning — United States, 2019
por: Kacha-Ochana, Akadia, et al.
Publicado: (2022)

A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population
por: Jewell, Jennifer, et al.
Publicado: (2023)

Correction to: A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population
por: Jewell, Jennifer, et al.
Publicado: (2023)

Comment on Mayock SP, Saim S, Fleming AB. In Vitro Drug Release After Crushing: Evaluation of Xtampza(®) ER and Other ER Opioid Formulations
por: Crudele, Nancy, et al.
Publicado: (2018)

Nonmedical Abuse of Benzodiazepines in Opiate-Dependent Patients in Tehran, Iran
por: Babakhanian, Masuade, et al.
Publicado: (2012)

Response to Crudele et al. Commentary on Mayock et al. “In Vitro Drug Release after Crushing: Evaluation of Xtampza(®) ER and Other ER Opioid Formulations”
por: Fleming, Alison B., et al.
Publicado: (2018)

Nonmedical Use of Prescription ADHD Stimulants and Preexisting Patterns of Drug Abuse
por: Sweeney, Christine T., et al.
Publicado: (2013)

Relative Oral Bioavailability of an Abuse-Deterrent, Immediate-Release Formulation of Oxycodone, Oxycodone ARIR in a Randomized Study
por: Webster, Lynn R., et al.
Publicado: (2019)

Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxycodone with abuse-deterrent characteristics
por: Coplan, Paul M, et al.
Publicado: (2013)

Teen Addiction Severity Index (T-ASI): Hindi Translation and Validation for Use in India
por: Sharma, Renu, et al.
Publicado: (2022)

Abuse Potential of Intravenous Oxycodone/Naloxone Solution in Nondependent Recreational Drug Users
por: Colucci, Salvatore V., et al.
Publicado: (2014)

Targeting Nicotine Addiction in a Substance Abuse Program
por: Sharp, James R., et al.
Publicado: (2003)

Comparison of the Risks of Shopping Behavior and Opioid Abuse Between Tapentadol and Oxycodone and Association of Shopping Behavior and Opioid Abuse
por: Cepeda, M. Soledad, et al.
Publicado: (2014)

Así.
Publicado: (1940)

Nonmedical use of prescription drugs: A comparison between intoxication-oriented and other nonmedical users
por: Piispa, Ilona, et al.
Publicado: (2021)

How Motivations for Using Buprenorphine Products Differ From Using Opioid Analgesics: Evidence from an Observational Study of Internet Discussions Among Recreational Users
por: Butler, Stephen F, et al.
Publicado: (2020)

Nonmedical prescription drug users in private vs. public substance abuse treatment: a cross sectional comparison of demographic and HIV risk behavior profiles
por: O’Grady, Catherine L, et al.
Publicado: (2014)

Oxycodone/Naloxone: Role in Chronic Pain Management, Opioid-Induced Constipation, and Abuse Deterrence
por: DePriest, Anne Z., et al.
Publicado: (2014)

Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse
por: Raleigh, M. D., et al.
Publicado: (2017)

Oxycodone hydrochloride immediate-release analgesic for managing severe pain: abuse-deterrent formulations
por: Kibbe, AH, et al.
Publicado: (2018)

Human Abuse Potential of the New Opioid Analgesic Molecule NKTR-181 Compared with Oxycodone
por: Webster, Lynn, et al.
Publicado: (2018)

Overlap between substance and behavioural addictions: substance abuse in patients with pathological gambling
por: Cunha E Costa, N., et al.
Publicado: (2022)

Nonmedical use of sedatives in urban Bengaluru
por: Nattala, Prasanthi, et al.
Publicado: (2014)

Macular Burns from Nonmedical Lasers
por: Sayman Muslubaş, Işıl, et al.
Publicado: (2016)

Comparison of Real-world Outcomes Between Patients Treated with Tapentadol ER or Oxycodone CR
por: Durkin, Mike, et al.
Publicado: (2015)

Así fué ...
por: Gamboa, Héctor
Publicado: (1994)

¡Así gané! /
por: González R., Raúl (González Rodríguez), 1952-
Publicado: (2008)

Así pasan...
por: Dávalos, Marcelino 1871-1923
Publicado: (1994)

Pasó así
por: Traba, Marta 1930-
Publicado: (1963)

Así pasan...
por: Dávalos, Marcelino, 1871-1923
Publicado: (1945)

Así somos
por: Brandon, Henry
Publicado: (1962)

Cannot write session to /tmp/vufind_sessions/sess_u9qer15iuirvgtr2ss293c2vn9